Trace Bilirubin and Ketones on Urinalysis: Clinical Significance and Management
In an asymptomatic patient with normal liver function tests, normal lipid panel, uACR <30 mg/g, and fasting glucose of 102 mg/dL, trace bilirubin and ketones on urinalysis are clinically insignificant and require no specific management beyond addressing the borderline glucose.
Understanding the Findings
Trace Urinary Bilirubin
The presence of trace bilirubin on urinalysis in this clinical context is not concerning. Here's why:
Normal serum liver function tests exclude clinically significant bilirubinemia. The 2018 Gut guidelines emphasize that bilirubin abnormalities of clinical significance manifest as elevated serum total bilirubin, not isolated trace urinary findings 1.
Urinary bilirubin detection on dipstick is notoriously prone to false positives from concentrated urine, certain medications, or prolonged specimen storage 2.
Conjugated bilirubin is the only form excreted in urine. Since your patient has normal serum liver tests, there is no hepatocellular injury or biliary obstruction to produce clinically meaningful bilirubinuria 3.
The most common cause of isolated elevated serum bilirubin (when it occurs) is Gilbert's syndrome, which involves unconjugated hyperbilirubinemia that does not appear in urine and requires only reassurance 1.
Trace Urinary Ketones
Trace ketones are physiologically normal in this scenario:
Fasting state commonly produces trace ketonuria without pathology 2.
With a glucose of 102 mg/dL (impaired fasting glucose range: 100-125 mg/dL), this patient is not hyperglycemic enough to suggest diabetic ketoacidosis.
Trace ketones can occur from recent exercise, low-carbohydrate diet, or even mild dehydration 2.
What Actually Matters: The Glucose of 102 mg/dL
The clinically significant finding here is the fasting glucose of 102 mg/dL, which indicates impaired fasting glucose (prediabetes):
- This warrants lifestyle modification counseling (diet, exercise, weight management).
- Consider hemoglobin A1c testing to better characterize glycemic status.
- Repeat fasting glucose or oral glucose tolerance test in 1 year if A1c is normal.
- Screen for other cardiovascular risk factors.
Recommended Management Algorithm
- No further workup needed for trace bilirubin/ketones given normal LFTs
- Confirm the urinalysis findings were not from a contaminated or old specimen (if concerned, simply repeat)
- Focus on the glucose abnormality:
- Order hemoglobin A1c
- Provide diabetes prevention counseling
- Assess cardiovascular risk factors
- Schedule follow-up in 3-6 months
Common Pitfalls to Avoid
Do not order serum bilirubin fractionation or hepatobiliary imaging for trace urinary bilirubin when LFTs are normal—this represents unnecessary testing 4, 5.
Do not assume trace ketones indicate diabetes when glucose is only mildly elevated and the patient is asymptomatic 2.
Do not ignore the impaired fasting glucose while chasing irrelevant urinalysis findings—the glucose abnormality carries actual cardiovascular and metabolic risk.
Recognize that dipstick urinalysis has limited specificity for trace findings, particularly bilirubin and ketones, which are often false positives in asymptomatic patients 2.
The evidence consistently shows that asymptomatic patients with normal serum liver biochemistry do not require investigation for trace urinary bilirubin 1, 4, 5. The 2018 Gut guidelines make clear that clinical significance is determined by serum testing and clinical context, not isolated urinalysis abnormalities 1.